** Brokerage Morgans hikes price target on Australian
infection prevention solutions provider Nanosonics Ltd NAN.AX
to A$5.49 from A$5.24, upgrades rating to "add" from "hold"
** Hikes rating and PT citing recent share weakness; says
there's now around 10% upside to the new PT
** NAN lost nearly 12% in May, marking its worst monthly
loss since September 2022
** Says continue to expect NAN to achieve FY23 sales growth
guidance of between 36% to 41%
** Adds that order volumes are increasing and inventory
levels are capable of handling higher throughput
** Three of 11 analysts rate the stock "buy" or higher,
three "hold" and five "sell" or lower; their median PT is A$4.70
– Refinitiv data
** NAN trading 0.4% lower, as at 0514 GMT
(Reporting by Sameer Manekar in Bengaluru)
((Sameer.Manekar@thomsonreuters.com; Twitter: https://twitter.com/sameer_manekar))